α3β1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutics for Non-Small Cell Lung Cancer Treatment

2020 
Docetaxel (DTX) widely used for treating non-small cell lung cancer (NSCLC) patients is associated with dose-limiting side effects primarily neurotoxicity and myelosuppression. Here, we have develo...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    50
    References
    12
    Citations
    NaN
    KQI
    []